Table of Contents Table of Contents
Previous Page  92 / 94 Next Page
Information
Show Menu
Previous Page 92 / 94 Next Page
Page Background

90

NCCN Guidelines for Patients

®

Hodgkin Lymphoma, Version 1.2015

Index

Index

blood chemistry profile

50–51, 64–66

bone marrow aspiration

29

bone marrow biopsy

15, 18

chemotherapy

19, 24–26, 28–29, 31, 37, 39, 42–43,

46–49, 53, 58–63, 67

chest x-ray

15, 18

classical Hodgkin lymphoma

8, 30–31, 36–54

clinical trial

32–33, 73

complementary and alternative medicine

33

complete blood count

15–16, 50–52, 64–66

comprehensive metabolic panel

15–16

computed tomography

15, 17–18, 27, 37, 50–53, 64–67

distress

15,

20

ejection fraction

15, 19

erythrocyte sedimentation rate

15–16

excisional biopsy

10

fertility

15, 20, 50–53, 64–67

immunohistochemistry

10

immunomodulator

25, 30

involved-site radiation therapy

27

liver function tests

15–16

lymphatic system

6–9

lymphocyte

7–8

lymphoma

8

magnetic resonance imaging

27, 53, 67

medical history

14–15, 50–52, 64–66

NCCN Member Institutions

88

NCCN Panel Members

87

nodular lymphocyte-predominant Hodgkin

lymphoma

8, 31, 56–68

positron emission tomography/computed

tomography

15, 17, 27, 37, 51, 58, 60, 62, 65

pulmonary function tests

15, 19, 37

Reed-Sternberg cells

8

smoking

15, 20, 50–53, 64–67

stem cell transplant

26, 28–30, 46–49

total lymphoid irradiation

47, 49